• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Is Heavy Menstrual Bleeding a Sign of a Bleeding Disorder in Adolescents?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Von Willebrand disease, a genetic disorder, results in a quantitative or qualitative deficiency of von Willebrand factor
  • Menorrhagia beginning at menarche is often the first presenting symptom but the underlying cause often goes unrecognized
  • ACOG recommends screening for bleeding disorders in adolescents with menorrhagia and ≥1 of the following
    • Menses longer than 7 days or bleeding through a pad or tampon in 2 hours
    • Anemia
    • Family history of a bleeding disorder
    • History of bleeding after a hemostatic challenge (e.g., tooth extraction or surgery)
  • O’Brien et al. (Journal of Pediatric & Adolescent Gynecology, 2018) examined the prevalence of bleeding disorders in adolescents with heavy menstrual bleeding (HMB)

METHODS:

  • Retrospective review
  • Adolescents f between 8-18 years with HMB
  • Primary outcome: Diagnosis of a bleeding disorder
  • Secondary outcomes
    • Iron deficiency | Anemia | Various treatment modalities

RESULTS:

  • 124 patients were included in the study
    • 77 were screened for a bleeding disorder
  • 27 were diagnosed with a bleeding disorder
    • 21.7% of overall population
    • 35% of screened population
  • Of the group of bleeding disorders
    • Von Willebrand Disease: 51.6%
    • Inherited platelet function disorder: 33.3%
    • Thrombocytopenia (inherited or acquired): 11.1%
    • Factor IX deficiency: 3.7%
  • Iron deficiency and/or anemia were diagnosed in
    • 49.5% of screened patients
    • 70.3% of those diagnosed with a bleeding disorder

CONCLUSION:

  • This data confirms the importance of screening adolescents with heavy menstrual bleeding for bleeding disorders

Learn More – Primary Sources:

Bleeding disorders in Adolescents with Heavy Menstrual Bleeding (HMB): The Queensland Statewide Paediatric and Adolescent Gynaecology Service


Now You Can Get Clinical Research Summaries Direct to Your Email/Text | Tap Here to Learn More

 

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Are We Meeting the ACOG Screening Guidelines for Von Willebrand Disease in Adolescents with Menorrhagia?
Managing Abnormal Uterine Bleeding with Ovulatory Dysfunction
IUD, Hysterectomy or Ablation for Menorrhagia?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site